Steven Cohen’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
Steven Cohen's CRVS Position: Q3 2026 in Review
Steven Cohen opened a new position in Corvus Pharmaceuticals (CRVS) in Q3 2026: 435,146 shares worth $5.01M. The stake represents 0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CRVS as recently as Q4 2025.
Steven Cohen first reported a position in CRVS in Q1 2017 and has held it in 14 quarters since. The position peaked at $47.6M in Q3 2025. 176 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.
- Steven Cohen held 435,146 shares of Corvus Pharmaceuticals worth $5.01M as of Q3 2026.
- Corvus Pharmaceuticals was a new Steven Cohen position in Q3 2026.
- Corvus Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1809 holding.
- Steven Cohen first reported a position in Corvus Pharmaceuticals in Q1 2017 and has held it in 14 quarters since.
- Steven Cohen's Corvus Pharmaceuticals position peaked at $47.6M in Q3 2025.
- 176 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.